You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ABUS Disposition Disclosure
Androski Lindsay · SEC Form 4 · Filed Oct 7, 2026
Disposition
Calculated transaction value
$123.28K
Androski Lindsay President And CEO
Transaction date
Oct 1, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 6 days later
ABUS daily price context
Close on/before transaction
$4.56
Oct 1, 2026
First close after public filing
$4.18
Oct 8, 2026
30-day return after filing
-12.56%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 24,655 shares @ $5
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001447028-26-000058
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$123.28K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arbutus Biopharma Corp ABUS Current | Disposition | Oct 1, 2026 | $123.28K |